anti-LIF mAb (Translational Genomics Research Institute)

N/A

Report date: 2025/03/14 16:55:51

Base Information

Drug Nameanti-LIF mAb (Translational Genomics Research Institute)
Drug Alias Nameanti-leukemia inhibitory factor monoclonal antibody (Translational genomics research institute)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionLeukemia inhibitory factor receptor modulators
TargetsLeukemia inhibitory factor receptor
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTranslational Genomics Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesTranslational Genomics Research Institute
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A